Self-Assessment: Metastatic Prostate Cancer

ASCO Education

English - November 15, 2017 15:00 - 3 minutes - 1.67 MB - ★★★★ - 19 ratings
Medicine Health & Fitness Education asco oncology cancer health medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Recently Approved Drugs: Pembrolizumab for cHL

Next Episode: Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

Dr. Janice Dutcher, Associate Director of the Cancer Research Foundation of New York and medical oncology co-chair of the NCI Renal Cancer Task Force, presents a self-assessment question on the treatment of castrate-resistant metastatic prostate cancer.